Research programme: anti-infectives - Albany Molecular Research/IntraBiotics
Alternative Names: Anti-infectives research programme: Albany Molecular Research/IntraBioticsLatest Information Update: 09 Oct 2002
At a glance
- Originator Albany Molecular Research Inc; Ardea Biosciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Mycoses
Most Recent Events
- 09 Oct 2002 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 09 Oct 2002 Discontinued - Preclinical for Mycoses in USA (unspecified route)
- 22 Feb 2001 Preclinical development for Bacterial infections in USA (Unknown route)